𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice

✍ Scribed by Patricia J. McLaughlin; Roger J. Levin; Ian S. Zagon


Book ID
117467881
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
210 KB
Volume
199
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Defects in the opioid growth factor rece
✍ Patricia J. McLaughlin; Brendan C. Stack Jr.; Roger J. Levin; Fred Fedok; Ian S. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 541 KB

## Abstract ## BACKGROUND The endogenous opioid peptide, [Met^5^]‐enkephalin, termed opioid growth factor (OGF), interacts with its receptor (OGFr) to play a role as a constitutively expressed inhibitory growth factor in the proliferation of epithelial cells. This study compared protein and gene e

Epidermal growth factor receptor targete
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR